文献速递临床试验与 GCP流行病学与生物统计

肯尼亚预防母婴传播项目短信干预对HIV病毒抑制与随访保留的三臂随机临床试验

SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial.
PubMed 文献 · PLoS Med · 2021-05-24

该三臂随机试验在肯尼亚6个母婴保健诊所比较双向短信、单向短信与无短信对HIV感染孕产妇HIV结局和母婴保健的影响。824名孕妇随机入组,随访至产后2年。结果显示整合HIV/母婴保健短信未改善病毒抑制、按时就诊或婴儿HIV无感染生存,但双向短信组产后避孕启动时间显著更短。

要点

  • 整合HIV与母婴保健短信未改善病毒抑制、按时就诊及婴儿HIV无感染生存。
  • 双向短信组产后避孕启动时间较对照组显著缩短。
  • 在多数女性已获病毒抑制的项目中,可考虑基于病毒载量数据开展靶向短信干预。

核心结论

  • 整合HIV/母婴保健短信未改善HIV结局,但与产后避孕启动改善相关。
  • 在多数女性病毒抑制的项目中,基于病毒载量数据的靶向短信可能提高有效性。
  • 严格评估对优化移动健康干预仍很重要。

研究设计与样本

  • 研究为在肯尼亚6个母婴保健诊所开展的三臂随机临床试验,比较双向短信、单向短信与无短信。
  • 824名孕妇于2015年11月至2017年5月随机入组,中位年龄27岁,中位孕周24.3周,ART启动后中位时间1.0年。
  • 短信基于健康信念模型和社会认知理论开发,HIV信息整合入现有母婴保健短信平台。
  • 干预组接受就诊提醒和预设每周短信,内容涉及ART依从性与母婴保健,并按特征和时机定制;双向组可按需给护士发信息。
  • 随访至产后2年,主要结局为病毒未抑制(VL≥1,000 c/ml)、按时就诊、临床照护失访和婴儿HIV无感染生存。

主要发现

  • 随访期间3,150次VL检测中9.8%显示未抑制,19.6%的女性曾出现未抑制。
  • 单向短信组病毒未抑制11.2% versus 对照组9.6%,aRR 1.02(95%CI 0.67–1.54),p=0.94。
  • 双向短信组病毒未抑制8.5% versus 对照组9.6%,aRR 0.80(95%CI 0.52–1.23),p=0.31。
  • 总体88.9%(95%CI 76.5–95.7)就诊按时,各组无显著差异(对照组88.2%、单向组88.6%、双向组88.8%)。
  • 婴儿HIV感染或死亡发生率为3.01/100人年,各组无显著差异;婴儿HIV感染风险为0.94%。

关键数值与推荐

  • 病毒未抑制定义为VL≥1,000 c/ml。
  • 主要结局包括病毒未抑制、按时就诊、临床照护失访和婴儿HIV无感染生存。
  • 双向短信组产后避孕启动时间较对照组显著缩短。

临床怎么用

  • 在病毒抑制率高的预防母婴传播项目中,常规整合短信未必改善HIV结局。
  • 可考虑利用病毒载量数据识别未抑制者,实施靶向短信干预。
  • 双向短信可能有助于促进产后避孕启动。

局限性

  • 因病毒抑制和按时就诊比例已较高,研究检测改善的能力有限。
  • 短信提醒与就诊时间的同步不够完善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pregnant and postpartum women living with HIV (WLWH) need support for HIV and maternal child health (MCH) care, which could be provided using short message service (SMS). METHODS AND FINDINGS: We compared 2-way (interactive) and 1-way SMS messaging to no SMS in a 3-arm randomized trial in 6 MCH clinics in Kenya. Messages were developed using the Health Belief Model and Social Cognitive Theory; HIV messages were integrated into an existing MCH SMS platform. Intervention participants received visit reminders and prespecified weekly SMS on antiretroviral therapy (ART) adherence and MCH, tailored to their characteristics and timing. Two-way participants could message nurses as needed. Clinic attendance, viral load (VL), and infant HIV results were abstracted from program records. Primary outcomes were viral nonsuppression (VL ≥1,000 c/ml), on-time clinic attendance, loss to follow-up from clinical care, and infant HIV-free survival. Among 824 pregnant women randomized between November 2015 and May 2017, median age was 27 years, gestational age was 24.3 weeks, and time since initiation of ART was 1.0 year. During follow-up to 2 years postpartum, 9.8% of 3,150 VL assessments and 19.6% of women were ever nonsuppressed, with no significant difference in 1-way versus control (11.2% versus 9.6%, adjusted risk ratio (aRR) 1.02 [95% confidence interval (CI) 0.67 to 1.54], p = 0.94) or 2-way versus control (8.5% versus 9.6%, aRR 0.80 [95% CI 0.52 to 1.23], p = 0.31). Median ART adherence and incident ART resistance did not significantly differ by arm. Overall, 88.9% (95% CI 76.5 to 95.7) of visits were on time, with no significant differences between arms (88.2% in control versus 88.6% in 1-way and 88.8% in 2-way). Incidence of infant HIV or death was 3.01/100 person-years (py), with no significant difference between arms; risk of infant HIV infection was 0.94%. Time to postpartum contraception was significantly shorter in the 2-way arm than control. Study limitations include limited ability to detect improvement due to high viral suppression and visit attendance and imperfect synchronization of SMS reminders to clinic visits. CONCLUSIONS: Integrated HIV/MCH messaging did not improve HIV outcomes but was associated with improved initiation of postpartum contraception. In programs where most women are virally suppressed, targeted SMS informed by VL data may improve effectiveness. Rigorous evaluation remains important to optimize mobile health (mHealth) interventions. TRIAL REGISTRATION: ClinicalTrials.gov number NCT02400671.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Kinuthia J, Ronen K, Unger JA, et al. SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial. PLoS Med. 2021. PMID: 34029338. doi:10.1371/journal.pmed.1003650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。